ARIA-suggested drugs for allergic rhinitis:: what impact on quality of life?: A GA2LEN review

被引:43
作者
Baiardini, I. [1 ]
Braido, F. [1 ]
Tarantini, F. [1 ]
Porcu, A. [1 ]
Bonini, S. [2 ]
Bousquet, P. -J. [3 ]
Zuberbier, T. [4 ]
Demoly, P. [3 ]
Canonica, G. W. [1 ]
机构
[1] Univ Genoa, DIMI, Genoa, Italy
[2] Univ Naples 2, Naples, Italy
[3] Hop Arnaud Villeneuve, INSERM, U454, Montpellier, France
[4] Charite, Dept Dermatol & Allergy, Allergy Centrum Charite, D-13353 Berlin, Germany
关键词
allergic rhinitis and its impact on asthma; quality of life; rhinitis;
D O I
10.1111/j.1398-9995.2008.01649.x
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
Allergic diseases constitute a global health problem, as they have an increasing economic and social impact and, especially, they can deeply interfere with the patients' daily life, being a cause of physical and emotional discomfort. This is why the health-related quality-of-life (HRQoL) has become increasingly important in health care research; in fact, the assessment of the impact the disease and its treatment have on patients, provides a more comprehensive approach in outcome evaluation. Numerous validated questionnaires are available and many studies have been performed evaluating HRQoL in people affected by allergic rhinitis (AR), thus testifying a great interest in this topic. The aims of the present review are: to examine the scientific literature of the last 3 years dealing with the impact of AR treatments suggested by allergic rhinitis and its impact on asthma guidelines on patients' QoL, and to identify the unexplored or not-fully-investigated areas concerning this issue.
引用
收藏
页码:660 / 669
页数:10
相关论文
共 50 条
[1]   The effect of Fel d 1-derived T-cell peptides on upper and lower airway outcome measurements in cat-allergic subjects [J].
Alexander, C ;
Tarzi, M ;
Larché, M ;
Kay, AB .
ALLERGY, 2005, 60 (10) :1269-1274
[2]   Immunotherapy with depigmented glutaraldehyde-polymerized extracts:: changes in quality of life [J].
Alvarez-Cuesta, E ;
Aragoneses-Gilsanz, E ;
Martín-Garcia, C ;
Berges-Gimeno, P ;
Gonzalez-Mancebo, E ;
Cuesta-Herranz, J .
CLINICAL AND EXPERIMENTAL ALLERGY, 2005, 35 (05) :572-578
[3]  
[Anonymous], HDB BAS DOC
[4]   Worldwide time trends in the prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and eczema in childhood:: ISAAC Phases One and Three repeat multicountry cross-sectional surveys [J].
Asher, M. Innes ;
Montefort, Stephen ;
Bjorksten, Bengt ;
Lai, Christopher K. W. ;
Strachan, David P. ;
Weiland, Stephan K. ;
Williams, Hywel .
LANCET, 2006, 368 (9537) :733-743
[5]   Levocetirizine improves quality of life and reduces costs in long-term management of persistent allergic rhinitis [J].
Bachert, C ;
Bousquet, J ;
Canonica, GW ;
Durham, SR ;
Klimek, L ;
Mullol, J ;
Van Cauwenberge, PB ;
Van Hammée, G .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2004, 114 (04) :838-844
[6]   Sleep disturbances in allergic diseases [J].
Baiardini, I. ;
Braido, F. ;
Cauglia, S. ;
Canonica, G. W. .
ALLERGY, 2006, 61 (11) :1259-1267
[7]   Allergic diseases and their impact on quality of life [J].
Baiardini, Ilaria ;
Braido, Fulvio ;
Brandi, Silvia ;
Canonica, Giorgio Walter .
ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2006, 97 (04) :419-428
[8]   Effects of levocetirizine as add-on therapy to fluticasone in seasonal allergic rhinitis [J].
Barnes, ML ;
Ward, JH ;
Fardon, TC ;
Lipworth, BJ .
CLINICAL AND EXPERIMENTAL ALLERGY, 2006, 36 (05) :676-684
[9]   Comparison of the effects of fluticasone propionate aqueous nasal spray and loratadine on daytime alertness and performance in children with seasonal allergic rhinitis [J].
Bender, BG ;
Milgrom, H .
ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2004, 92 (03) :344-349
[10]   Effects of adjuvant therapy with 0.1% olopatadine hydrochloride ophthalmic solution on quality of life in patients with allergic rhinitis using systemic or nasal therapy [J].
Berger, W ;
Abelson, MB ;
Gomes, PJ ;
Beck, M ;
Kimura, S ;
Westbrook, T ;
Storms, W ;
Galant, S .
ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2005, 95 (04) :361-371